Moritoshi Kinoshita

2.9k citations
75 papers · 2.3k indexed · h-index 28

Moritoshi Kinoshita

75 papers receiving 2.3k citations

Peers

Moritoshi Kinoshita
Comparison fields: 5 of 94
  • Pharmacology 496
  • Hepatology 341
  • Oncology 538
  • Molecular Biology 1.0k
  • Epidemiology 498
Replace Hideyuki Miyoshi with:
Hideyuki Miyoshi Japan
Andrew Gibson United States
Claudia Fuchs Austria
Akari Suzuki Japan
Oliver Krenkel Germany
E P Sampaio Brazil
Tangsheng Yi United States
J Piris United Kingdom
Minnie Y.Y. Go Hong Kong
K Tanikawa Japan
Moritoshi Kinoshita relative to Hideyuki Miyoshi Japan Hideyuki Miyoshi's profile →
Citations per field
00.5×1.5×
Hideyuki Miyoshi · 1×
Citations per year

Countries citing papers authored by Moritoshi Kinoshita

Since Specialization
Citations

This map shows the geographic impact of Moritoshi Kinoshita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moritoshi Kinoshita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moritoshi Kinoshita more than expected).

Fields of papers citing papers by Moritoshi Kinoshita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moritoshi Kinoshita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moritoshi Kinoshita. The network helps show where Moritoshi Kinoshita may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Moritoshi Kinoshita, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Moritoshi Kinoshita Line = papers co-authored together Moritoshi Kinoshita links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20177
2 20049
3 20024
4 200280
5 200125
6 20002
7 2000105
8 199958
9 19996
10 199954
11 199995
12 199899
13 19973
14 199754
15 199631
16 199642
17 19942
18 19931
19 199259
20
[A case of amyotrophic lateral sclerosis with disturbance of vertical ocular movement responding to thyrotropin releasing hormone (TRH)].
19912

About Moritoshi Kinoshita

Moritoshi Kinoshita is a scholar working on Hepatology, Pharmacology and Epidemiology, having authored 75 papers that have together received 2.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (12 papers), Pharmacogenetics and Drug Metabolism (11 papers), Hepatitis B Virus Studies (11 papers), Cancer-related Molecular Pathways (6 papers), Lung Cancer Treatments and Mutations (6 papers), Molecular Biology Techniques and Applications (6 papers), Cervical Cancer and HPV Research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Pharmacology (496 citations), Hepatology (341 citations) and Oncology (538 citations). Moritoshi Kinoshita has collaborated with scholars based in Japan, Spain and United States. Frequent co-authors include Tetsuya Kamataki, Tsuyoshi Yokoi, Masahiko Miyata, Takafumi Fukui, Michihiro Chida, Ken‐ichi Nunoya, Tomohiro FUKUI, S. Nakamori, Kyoko Iwao and Yusuke Nakamura. Their work appears in journals such as Blood, PLoS ONE and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026